In the wake of a high-profile federal court ruling casting doubt on the definition of eligible “patient” in the 340B [...] …
Month: December 2023
The federal 340B program remains on track to publish a final rule this month revising its administrative dispute resolution (ADR) [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Stakeholder comments are due Tuesday on Minnesota’s recently published guidance to implement one of the nation’s first state laws requiring [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
At the start of 2024, Michigan 340B hospitals can bill the state at higher payment rates for outpatient drugs; later [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Novo Nordisk will issue its fifth round of refunds this year on prices charged to 340B providers. The latest are [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The U.S. House of Representatives last night passed a sweeping healthcare package that would require 340B providers to publicly report [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Months after it was expected, bipartisan legislation to prevent drugmaker restrictions on the use of contract pharmacies by 340B providers [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A Missouri state senator has filed to reintroduce a bill that would bar drugmaker 340B contract pharmacy restrictions and pharmacy [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Just a week after Wisconsin state senators introduced a bipartisan bill to bar disparate treatment of 340B providers by pharmacy [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Pharmaceutical company executives discussed a range of 340B-related developments in recent third quarter investor calls. An executive for BioMarin Pharmaceutical, [...] …